Global Down Syndrome

2018 Issue 4 of 4

Issue link: https://viewer.e-digitaledition.com/i/1080513

Contents of this Issue

Navigation

Page 12 of 31

TESTICULAR CANCER: THE EXCEPTION TO THE RULE Men with Down syndrome are two to three times more likely than typical men to develop testicular cancer. This is one of very few solid tumor cancers that affect people with Down syndrome at a similar or higher rate than the typical population. One theory about this risk has to do with activated killer T cells, a type of immune cell that attacks tumors. JoaquĆ­n Espinosa, Ph.D., Executive Director of the Linda Crnic Institute for Down Syndrome, and his lab have shown and are researching immune system dysregulation in people with Down syndrome. One result of this dysregulation is that, on average, people with Down syndrome have more than twice as many activated killer T cells as typical people. This may help protect them from almost every solid tumor cancer. However, because the human body prohibits killer T cells from entering the testicles, having those higher levels provides no advantage against testicular cancer for people with Down syndrome, according to Dr. Espinosa. Men may be more likely to develop testicular cancer if they have an undescended testicle, a personal or family history of the disease, or HIV infection, the American Cancer Society reports. While not all cases cause symptoms, a lump on or swelling of a testicle is often the first sign of testicular cancer and warrants immediate medical attention. GLOBALDOWNSYNDROME.ORG 13

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - 2018 Issue 4 of 4